Key result
Cardiovascular diseases had an incidence of 13.6% in oncological patients, which was associated with exposure to radiotherapy and chemotherapy.
Why the study?
Cancers are related to cardiovascular diseases mainly due to the cardiotoxicity of oncological therapies, motivating analysis of CVDs affecting cancer patients before and after diagnosis.
Does oncological therapy increase the incidence of cardiovascular diseases in oncological patients?
Cohort (n=250)
No
Does oncological therapy increase the incidence of cardiovascular diseases in oncological patients?
In a Brazilian cohort of cancer patients, incident cardiovascular diseases occurred in 13.6% of patients and were significantly associated with radiotherapy and specific chemotherapies (fluorouracil and oxaliplatin).
Answers are grounded in this paper and cite their sources.
May warrant cardiovascular surveillance in treated cancer patients; leaves open causality in this observational cohort.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lorencini et al. (2023) conducted a cohort in Cancer (n=250). Oncological therapies (radiotherapy and chemotherapy) was evaluated on Incidence of cardiovascular diseases after cancer diagnosis. Cardiovascular diseases had an incidence of 13.6% in oncological patients, which was associated with exposure to radiotherapy and chemotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: